非酒精性脂肪性肝病与女性全因死亡率及癌症、心血管疾病和肝病死亡率增加相关,而与男性无关
在韩国 318,224 名成年人中,中位随访 5.7 年期间,非酒精性脂肪性肝病(NAFLD)与女性全因死亡(HR 1.79)、癌症死亡(HR 1.83)、心血管疾病死亡(HR 1.63)和肝病死亡(HR 5.58)独立相关,但男性中未观察到这些关联。
要点
- 女性 NAFLD 与全因死亡风险升高相关(HR 1.79,95%CI 1.50-2.14)。
- 女性 NAFLD 与肝病死亡风险升高相关(HR 5.58,95%CI 1.79-17.39)。
- 男性 NAFLD 与癌症死亡风险降低相关(HR 0.79,95%CI 0.66-0.93)。
核心结论
- 在韩国人群中,NAFLD 与死亡率的关联存在性别差异:女性 NAFLD 与全因死亡及癌症、心血管疾病、肝病死亡风险增加相关,而男性中未观察到这些关联。
研究设计与样本
- 研究基于韩国 Kangbuk Samsung 健康研究队列,纳入 2002 年至 2012 年在首尔或水原接受年度或 biennial 健康检查的 318,224 名受试者(男性 165,131 名,女性 153,093 名),年龄 20 至 94 岁(平均年龄 39.3 岁)。
- NAFLD 通过超声诊断,并排除其他已知肝病;死亡信息来自韩国国家统计办公室的全国死亡证明数据(2002 年至 2012 年)。
主要发现
- 中位随访 5.7 年期间,累积全因死亡率为 0.51%(1613 例死亡),癌症是主要死因。
- 在男性中,调整年龄、体重指数、吸烟状态、每日酒精摄入量和体力活动后,NAFLD 与任何原因死亡风险增加无关,但与癌症死亡风险降低相关(HR 0.79;95%CI 0.66-0.93;P = .005)。
- 在女性中,NAFLD 独立与全因死亡(HR 1.79;95%CI 1.50-2.14;P < .0001)、癌症死亡(HR 1.83;95%CI 1.42-2.35;P < .0001)、心血管疾病死亡(HR 1.63;95%CI 1.00-2.66;P = .0498)和肝病死亡(HR 5.58;95%CI 1.79-17.39;P = .003)相关。
- 在肥胖男性中,NAFLD 与癌症死亡风险降低相关;在非肥胖男性中,NAFLD 与心血管疾病死亡风险增加相关。
- 在肥胖女性中,NAFLD 与单纯肥胖相比未增加死亡风险;在非肥胖女性中,NAFLD 与全因死亡风险和癌症死亡风险增加相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: It is not clear whether women vs men have increased mortality from nonalcoholic fatty liver disease (NAFLD). We investigated whether NAFLD is associated with increased overall and cause-specific deaths in a Korean population using a large health study database. METHODS: We collected data on 318,224 subjects in Korea (165,131 men and 153,093 women) age 20 to 94 years (mean age, 39.3 y), enrolled in the Kangbuk Samsung Health Study cohort. All subjects underwent a comprehensive annual or biennial health examination in Seoul or Suwon, South Korea, from 2002 through 2012. The presence of NAFLD was ascertained by ultrasonography in the absence of other known liver diseases. Mortality (from 2002 through 2012) was determined by the nationwide death certificate data from the Korea National Statistical Office. RESULTS: During a median 5.7-year follow-up period, cumulative overall mortality was 0.51% (1613 deaths)-cancer was the leading cause of death. In men, NAFLD was not associated with increased mortality from any cause, except lower rate of death from cancer (hazard ratio, 0.79; 95% CI, 0.66-0.93; P = .005), after adjusting for age, body mass index, smoking status, daily alcohol consumption, and physical activity. In women, NAFLD was independently associated with death from all causes (hazard ratio, 1.79; 95% CI, 1.50-2.14; P < .0001), death from cancer (hazard ratio, 1.83; 95% CI, 1.42-2.35; P < .0001), death from cardiovascular disease (hazard ratio, 1.63; 95% CI, 1.00-2.66; P = .0498), and death from liver disease (hazard ratio, 5.58; 95% CI, 1.79-17.39; P = .003). In obese men, NAFLD was associated with a reduced risk of death from cancer. However, NAFLD was associated with increased risk of death from cardiovascular disease in nonobese men. In obese women, NAFLD did not increase risk of death compared with obesity alone. However, NAFLD was associated with increased overall risk of death and risk of death from cancer in nonobese women. CONCLUSIONS: Associations between NAFLD and mortality differ between men and women in Koreans. NAFLD was associated with increased overall mortality and death from cancer, cardiovascular disease, and liver disease in women, but these associations were not observed in men.
引用
- Hwang YC, Ahn HY, Park SW, et al. Nonalcoholic Fatty Liver Disease Associates With Increased Overall Mortality and Death From Cancer, Cardiovascular Disease, and Liver Disease in Women but Not Men. Clin Gastroenterol Hepatol. 2017. PMID: 29158157. doi:10.1016/j.cgh.2017.11.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。